NCT07178743View on ClinicalTrials.gov

Emulation of the PALOMA-2 Trial

Active, not recruitingOBSERVATIONAL
Enrollment

6,097

Participants

Timeline

Start Date

July 14, 2025

Primary Completion Date

October 31, 2025

Study Completion Date

October 31, 2025

Conditions
Advanced Breast Cancer
Interventions
DRUG

Initiation of palbociclib plus letrozole

Initiation of palbociclib plus letrozole described in electronic health records is used as the exposure.

DRUG

Initiation of letrozole

Initiation of letrozole described in electronic health records is used as the reference.

Trial Locations (1)

02120

Brigham and Women's Hospital, Boston

All Listed Sponsors
collaborator

Food and Drug Administration (FDA)

FED

lead

Brigham and Women's Hospital

OTHER